Install the app
How to install the app on iOS

Follow along with the video below to see how to install our site as a web app on your home screen.

Note: This feature may not be available in some browsers.


Higher Testosterone May Equal Lower Heart Risks

F.I.S.T.

Iron Killer
Jacked Immortal
EG Freak
Mutated
Board Donator
Fully Loaded
EG Cash
82,365
This is an older study and I don't want to get anyone upset by it but it has some great research proving the benefits Test has on ones heart.



Higher Testosterone May Equal Lower Heart Risks

Published October 05, 2011
Reuters

Elderly men with naturally higher levels of testosterone may be less likely to suffer a heart attack or stroke than those men with lower levels of the hormone, according to a study.

Findings published in the Journal of the American College of Cardiology showed that of 2,400 Swedish men in their 70s and 80s, those with the highest testosterone levels were less likely to suffer a heart attack or stroke over the next several years than men with the lowest levels.

But the results do not prove that testosterone itself deserves the credit, and it's too soon to recommend testosterone replacement to try to lower heart risks.

"What we can say is that elderly men with high testosterone levels are relatively protected against cardiovascular events, and therefore lower testosterone is a marker for increased cardiovascular risk," said Asa Tivesten, at Sahlgrenska University Hospital in Goteborg, Sweden, who led the study.

It's known that any serious health condition can lower testosterone levels, as can obesity. But in the study, the researchers accounted for a number of health factors -- including the men's weight, blood pressure and any diagnoses of diabetes, heart disease or stroke at the outset.

Of 604 men in the bottom quarter for levels of the "male" hormone at the study's start, 21 percent had a heart attack, severe chest pain or stroke over roughly five years.

That compared with roughly 16 percent of the 606 men who started out with the highest testosterone levels.

Even accounting for health factors, men in the highest-testosterone group still showed a 30 percent lower risk of heart disease or stroke compared with the other three-quarters of the study group.

But that doesn't rule out the possibility that something other than testosterone may be at work, said JoAnn Manson, chief of preventive medicine at Brigham and Women's Hospital in Boston, who was not involved in the study.

"Low testosterone may be a marker of other health conditions that put men at higher risk of cardiovascular disease," she said.

Potential reasons for why higher natural testosterone levels may be good for the heart include the fact that higher testosterone generally means less body fat and more lean muscle.

What's needed, she added, is evidence from clinical trials that actually test whether testosterone replacement in older men cuts the risk of heart disease and stroke.

Those trials are ongoing and so far, she noted, the results are mixed on whether testosterone replacement improves "intermediate" outcomes like cholesterol or blood sugar levels.

No one yet knows if it affects the ultimate outcomes of cardiovascular disease and lifespan.

"There are many unanswered questions, and I don't think this means that men should be trying to boost their testosterone with testosterone replacement therapy," she said.

The experience with hormone replacement therapy (HRT) in women offers a cautionary tale.

Before 2002, many women used HRT in the hopes of warding off heart disease and osteoporosis. Then a large U.S. clinical trial found that women given pills containing estrogen and progesterone actually had higher risks of blood clots, heart attack, stroke and breast cancer than women given placebo pills.

Now HRT is largely used only for treating severe hot flashes -- and then, only at the lowest dose and for the shortest time possible.

"So there are concerns about the risks in men," Manson said.

Among those are the potential for testosterone to contribute to blood clots, liver damage or prostate cancer.

"This is a study of endogenous (natural) hormone production. It does not provide information about what is happening when hormones are given as a therapy," Tiveston said.
 
The dark side of testosterone deficiency: III. Cardiovascular disease.
https://www.ncbi.nlm.nih.gov/pubmed/19342698


Traish AM1, Saad F, Feeley RJ, Guay A.
Author information
Abstract

A considerable body of evidence exists suggesting that androgen deficiency contributes to the onset, progression, or both of cardiovascular disease (CVD). The aim of this review is to evaluate the relationships between testosterone (T) deficiency and risk factors of CVD and to discuss the implications of androgen deficiency in men with cardiovascular risk factors. The relationship between androgen deficiency and endothelial function, lipid profiles, inflammatory responses, altered vascular smooth muscle reactivity, and hypertension are discussed with regard to CVD. A comprehensive literature search was carried out with the use of Pub Med from 1980 through 2009, and relevant articles pertinent to androgen deficiency and vascular disease were evaluated and discussed. Low T, whether attributed to hypogonadism or androgen deprivation therapy, in men with prostate carcinoma, produces adverse effects on cardiovascular health. Androgen deficiency is associated with increased levels of total cholesterol, low-density lipoprotein, increased production of proinflammatory factors, and increased thickness of the arterial wall and contributes to endothelial dysfunction. Testosterone supplementation restores arterial vasoreactivity; reduces proinflammatory cytokines, total cholesterol, and triglyceride levels; and improves endothelial function but also might reduce high-density lipoprotein levels. Testosterone is an anabolic hormone with a wide range of beneficial effects on men's health. The therapeutic role of T in men's health, however, remains a hotly debated issue for a number of reasons, including the purported risk of prostate cancer. In view of the emerging evidence suggesting that androgen deficiency is a risk factor for CVD, androgen replacement therapy could potentially reduce CVD risk in hypogonadal men. It should be emphasized, however, that androgen replacement therapy should be done with very thorough and careful monitoring for prostate diseases.
 

Create an account or login to comment

You must be a member in order to leave a comment

Create account

Create an account on our community. It's easy!

Log in

Already have an account? Log in here.

Latest threads

Back
Top